Lutathera

Active Ingredient(s): Lutetium Lu 177 Dotatate
FDA Approved: * January 26, 2018
Pharm Company: * ADVANCED ACCELERATOR APPLICATIONS USA INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lutathera 10 mci/Ml Intravenous Injection
NDC: 69488-003
Labeler:
Advanced Accelerator Applications USA, Inc

Related Brands

Drugs with the same active ingredients